三鑫医疗:2024年报净利润2.27亿 同比增长9.66%

Core Viewpoint - Sanxin Medical reported a net profit of 227 million yuan for 2024, reflecting a year-on-year growth of 9.66% [1] Financial Data and Indicators - Basic earnings per share increased to 0.4416 yuan, up 10.76% from 0.3987 yuan in 2023 [2] - Operating revenue reached 1.5 billion yuan, a 15.38% increase from 1.3 billion yuan in 2023 [2] - Net profit for the year was 227 million yuan, compared to 207 million yuan in 2023, marking a 9.66% increase [2] - Return on equity slightly decreased to 17.81% from 18.02% in the previous year [2] - The net asset per share was reported as 0, indicating a 100% decrease from 2.4 yuan in 2023 [2] Shareholder Structure - The top ten unrestricted shareholders collectively hold 95.6494 million shares, accounting for 26.84% of the circulating shares, with an increase of 8.7924 million shares compared to the previous period [2] - Notable shareholders include Peng Yixing with 32.2315 million shares (9.04%) and Wan Xiaoping with 16.9549 million shares (4.76%) [3] - New entrants among the top shareholders include Hai Life Insurance with 8.4447 million shares (2.37%) and another Hai Life Insurance product with 5.7763 million shares (1.62%) [3] Dividend Distribution - The company announced a dividend distribution plan of 2 yuan per share (including tax) [5]